Weekly round up from Life Sciences Industry.
Reuters reports that European antitrust regulators are about to sign off on Takeda’s takeover of Shire.
Previously: Takeda offers to divest Shire IBD candidate to satisfy European regulators on merger
Date: November 12, 2018
Source: Seeking Alpha
Send us an email, we will get in touch with you.
Sign up for DistilINFO e-Newsletters.
Arvinas’ Experimental Breast Cancer Drug Fails to Impress Analysts
Biosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents
Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit
Arcus Biosciences up 84% on Rumored Gilead Interest
M&A chatter has athenahealth moving on heavy volume
EyeCare Partners Completes Acquisition of Associated Retinal Consultants
NurseFly Announces Acquisition by IAC